Hoshino S, Imanishi J, Matsuoka H, Kishida T
Arch Virol. 1983;76(4):355-8. doi: 10.1007/BF01311202.
In our previous study we found that the ARH 77 human B lymphoblastoid cell line, originating from a patient with multiple myeloma, produced both human interferon-alpha (HuIFN-alpha) and HuIFN-beta after induction with Sendai virus. In order to examine whether IFN-alpha-producing ARH 77 cell clones can be separated from IFN-beta-producing ones, the ARH 77 line was cloned by the soft agar method. Twelve clones chosen at random were examined for IFN production and the antigenic types of IFN produced were determined. All examined clones simultaneously produced both HuIFN-alpha and HuIFN-beta, although the ratio of HuIFN-alpha to HuIFN-beta production was variable among the clones. This result suggests that one lymphoblastoid cell can produce both HuIFN-alpha and HuIFN-beta.
在我们之前的研究中,我们发现源自一名多发性骨髓瘤患者的ARH 77人B淋巴母细胞系在用仙台病毒诱导后可产生人α干扰素(HuIFN-α)和HuIFN-β。为了检测是否能从产生HuIFN-β的ARH 77细胞克隆中分离出产生HuIFN-α的克隆,采用软琼脂法对ARH 77细胞系进行克隆。随机选取12个克隆检测其干扰素产生情况,并确定所产生干扰素的抗原类型。尽管各克隆中HuIFN-α与HuIFN-β的产生比例各不相同,但所有检测的克隆均同时产生HuIFN-α和HuIFN-β。这一结果表明一个淋巴母细胞能够同时产生HuIFN-α和HuIFN-β。